Ablation of the CDK inhibitor p57(Kip2) results in increased apoptosis and delayed differentiation during mouse development

Genes and Development

Volumn 11, Issue 8, 1997, Pages 973-983

  Yan, Yimin ^a   Frisén, Jonas ^a,d   Lee, Mong Hong ^b,c   Massagué, Joan ^b   Barbacid, Mariano ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

apoptosis; Cell cycle; cyclin dependent kinase; development; differentiation

Indexed keywords

CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MALFORMATION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DEVELOPMENTAL DISORDER; DIGESTIVE SYSTEM MALFORMATION; EMBRYO; EMBRYO DEVELOPMENT; ETIOLOGY; GENE DELETION; GENE EXPRESSION; MOUSE; NONHUMAN; PALATE MALFORMATION; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030955563     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.8.973     Document Type: Article

References (54)

1. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Lacks, and G.J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
2. Cobrinik, D., M.-H. Lee, G. Hannon, G. Mulligan, R.T. Bronson, N. Dyson, E. Harlow, D. Beach, R.A. Weinberg, and T. Jacks. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes &. Dev. 10: 1633-1644.
3. Cohen, M.M. and R.J. Gorlin. 1971. The Beckwith-Wiedemann syndrome. Am. J. Dis. Child. 122: 515-519.
4. Datto, M.B., Y. Li, J.F. Panus, D.J. Howe, Y. Xiong, and X.-F. Wang. 1995. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. 92: 5545-5549.
5. de Noolj, J.C., M.A. Letendre, and I.K. Hariharan. 1996. A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from cell cycle during Drosophila embryogenesis. Cell 87: 1237-1247.
6. Cip1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
7. Eaton, A.P. and W.F. Maurer. 1971. The Beckwith-Wiedemann syndrome. Am. J. Dis. Child. 122: 520-525.
8. El-Deiry, W.S., J.W. Harper, P.M. O'Connor, V. Velculescu, C.E. Canman, J. Jackman, J. Pietenpol, M. Burell, D.E. Hill, W.E. Mercer, M.B. Kastan, K.W. Kohn, S.J. Elledge, K.W. Kinzler, and B. Volgelstein. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54: 1169-1174.
9. Ferguson, M.W.J. 1988. Palate development. Development (Suppl.) 103: 41-60.
10. Kip1 -deficient mice. Cell 85: 733-744.
11. Field, S., F.-Y. Tsai, F. Kuo, A.M. Zubiaga, W.G. Kaelin, Jr., D.M. Livingston, S.H. Orkin, and M.E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85: 549-561.
12. Hall, M. and G. Peters. 1996. Genetic alterations of cyclins, cyclin-dependent kinases and cdk inhibitors in human cancer. Adv. Cancer Res. 68: 67-108.
13. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261.
14. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
15. Kip2, a cyclin-dependent kinase inhibitor, in mouse. Nature Genet. 11: 204-206.
16. Kip2 is mutated in Beckwith-Wiedemann syndrome. Nature Genet. 14: 171-173.
17. Havely, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
18. Hunter, T. and J. Pines. 1994. Cyclins and cancer II: Cyclin D and CDK inhibitiors come of age. Cell 79: 573-582.
19. Jacks, T., A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295-300.
20. Joyner, A.L. 1993. Production of targeted embryonic stem cell clones. In Gene targeting. A practical approach (ed. D. Rickwood and B.D. Hames), pp. 33-61. Oxford Press, Oxford, UK.
21. Kip1) of cyclin-dependent kinase-4 activation. Cell 79: 487-496.
22. Kaufman, M.H. 1992. The atlas of mouse development. Academic Press, San Diego, CA.
23. Kessel, M. and P. Gruss. 1991. Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell 67: 89-104.
24. Kip1. Cell 85: 721-732.
25. Klein, R., R.J. Smeyne, W. Wurst, L.K. Long, B.A. Auerbach, A.L. Joyner, and M. Barbacid. 1993. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 75: 113-122.
26. Kip2 gene at 11pl5.5. Oncogene 12: 1365-1368.
27. Lane, M.E., K. Sauer, K. Wallace, Y.N. Jan, C.F. Lehner, and H. Vaessin. 1996. Dacapo, a cyclin-dependent kinase inhibitor, stops cell proliferation during Drosophila development. Cell 87: 1225-1235.
28. Lee, E.Y.-H.P., C.-Y. Chang, N. Hu, Y.-C.J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
29. Lee, E.Y.-H.P., N. Hu, S.-S.F. Yuan, L.A. Cox, A. Bradley, W.-H. Lee, and K. Herrup. 1994. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation. Genes & Dev. 8: 2008-2021.
30. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Dev. 9: 639-649.
31. Kip1 in neurons. Proc. Natl. Acad. Sci. 93: 3259-3263.
32. Liu, M., M.-H. Lee, M. Cohen, M. Bommakanti, and L.P. Freedman. 1996. Transcriptional activation of the Cd inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes & Dev. 10: 142-153.
33. Cip1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes & Dev. 9: 650-662.
34. Kip2, on chromosome 11p15. Proc. Natl. Acad. Sci. 93: 3026-3030.
35. McNamara, T.O., C.A. Gooding, S.L. Kaplan, and R.E. Clark. 1972. Exomphalos-macroglossia-gigantism (viceromegaly) syndrome. Am. J. Roentgenol. 114: 264-267.
36. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumor. Cell 85: 707-720.
37. Norbury, C. and P. Nurse. 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61: 441-470.
38. Kip1. Nature 372: 570-573.
39. Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
40. Kip1 a cyclin-cdk inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
41. Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes & Dev. 11: 492-503.
42. Reynisdóttir, I., K. Polyak, A. Iavarone, and J. Massagué. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes & Dev. 9: 1831-1845.
43. Kip1 cyclin-dependent kinase inhibitor bound to the cyclin A-cdk2 complex. Nature 382: 325-331.
44. Scrable, H., W. Cavenee, F. Ghavimi, M. Lowell, K. Morgan, and C. Sapienza. 1989. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc. Natl Acad. Sci. 86: 7480-7484.
45. Serrano, M., H.-W. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho. 1996. Role of the INK4a locus in tumor suppression. Cell 85: 27-37.
46. Sherr, C.J. and J.M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
47. Slingerland, J.M., L. Hengst, C. Pan, D. Alexander, M. Stampfer, and S.I. Reed. 1994. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14: 3683-3694.
48. Steinman, R.A., B. Hoffman, A. Iro, C. Guillouf, D.A. Liebermann, and M.E. El-Houseini. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396.
49. Kip2 in Wilms' tumor. Cancer Res. 56: 5723-5727.
50. Kip2 gene: Alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum. Genet. 97: 625-631.
51. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
52. Tybulewicz, V.L.J., C.E. Crawford, P.K. Jackson, R.T. Bronson, and R.C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-able proto-oncogene. Cell 65: 1153-1163.
53. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
54. Wiedemann, H.R. 1983. Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur. J. Pediatr. 141: 129.